Indicator leaflets are a tool to evaluate performance and impact of HBM4EU and link our key results to the objectives of the project as laid down in the description of action. The different leaflets have been designed with illustrative character including maps, figures and infographics on methodology to be easily interpretable with more outreach to the larger public.
In total, we have 23 indicator leaflets (presented in D6.2 – Revised set of key indicators), including 1 overview leaflet on project output indicators and 22 leaflets linking to the 5 overarching objectives and specific goals of HBM4EU. They provide information for 28 indicators as some of them have been grouped on one leaflet.
The indicator leaflets give very valuable information on the progress of HBM4EU in relation to the specific goals of the project. Combining the information from these leaflets in the frame of expected impacts will allow us to put forward conclusions towards impact and sustainability of HBM4EU.
Please download the leaflets from this link.
| Indicator Number | Indicator Title |
|---|---|
| 1.1 | Number of countries with an active national hub |
| 1.2 | Number of aligned human biomonitoring (HBM) studies within HBM4EU |
| 2.1 | Number of biomarkers for which exposure distributions and/or reference values are calculated within HBM4EU |
| 2.2 | Number of Human Biomonitoring Guidance Values (HBM-GVs) proposed by the HBM4EU consortium |
| 2.3 | Number of references to HBM4EU related HBM data in risk assessment |
| 3.1 | Number of candidate labs for chemical analysis, quality assurance/quality control (QA/QC) support and new analytical methods development |
| 3.2 | Number of qualified labs for chemical analysis |
| 4.1 | Number of scoping documents for prioritized substance groups |
| 3.3 | Number of exposure biomarkers covered in Interlaboratory Comparison Investigations (ICI) and External Quality Assessment Scheme (EQUAS) |
| 4.2 | Number of answers on rapid requests from policy makers |
| 4.3 | Number of existing combinations of HBM and health surveys |
| 5.1 | Number of human biomonitoring datasets available through IPCHeM |
| 6.1 | Number of chemicals/priority substances for which external and internal modelling predictions have been made (as in WP12) |
| 7.1 | Number of biomarkers of effect applied in joint HBM-studies within HBM4EU |
| 8.1 | Number of emerging (mixtures of) chemicals screened in human samples |
| 9.1 | Number of priority groups and number of individual chemicals for which links between exposures and human health outcomes have been described in the frame of HBM4EU (using AOPs or exploiting cohort studies) |
| 10.1 | Number of scientific training activities within consortium |
| 11.1 | Number of stakeholder consultations at European level for input in key HBM4EU processes |
| 11.2 | Number of science-policy interactions |
| 11.3 | Number of users and page views on the HBM4EU website |
| 11.4 | Number of followers on Twitter, Facebook and LinkedIn |
| 11.5 | Number of HBM4EU publications |
| 11.6 | Number of oral and poster publications |
| 11.7 | Number of HBM4EU events |
| 11.8 | Number of items and downloads in the online library (per category) |
| 11.9 | Number of reports in non-scientific traditional media |
| 11.10 | Number of published policy briefs |
| I.1 | Percentage of deliverables per year submitted on due date and accepted by the Commission |
| I.2 | Percentage of milestones reached at due date |